Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-20

Clinical Trial Update: Metabolic Effects of Betaine Supplementation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the metabolic effects of betaine supplementation in obesity and dysglycemia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaine (betaine (trimethylglycine))

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Obesity, Dysglycemia | Phase 2 | Status: COMPLETED | Results posted: 2021-04-20